0001415889-22-011004.txt : 20221102
0001415889-22-011004.hdr.sgml : 20221102
20221102163220
ACCESSION NUMBER: 0001415889-22-011004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221031
FILED AS OF DATE: 20221102
DATE AS OF CHANGE: 20221102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BILBREY JOHN P
CENTRAL INDEX KEY: 0001268386
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 221354641
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
form4-11022022_011109.xml
X0306
4
2022-10-31
0001739104
Elanco Animal Health Inc
ELAN
0001268386
BILBREY JOHN P
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
true
false
false
false
Deferred Stock Units
2022-10-31
4
A
0
669.699
13.19
A
Common Stock
669.699
13078.1399
D
Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.
/s/ Marcela A. Kirberger, as Attorney-in-Fact for John P. Bilbrey
2022-11-02